News

MD Anderson VC arm joins $25M funding round for cancer drug company | Health IT

By November 30, 2022No Comments

Cancer Focus Fund, a venture capital arm of Houston-based University of Texas MD Anderson Cancer Center, has joined a $25 million series A funding round for Nectin Therapeutics, which develops novel immunotherapies.Health IT

Leave a Reply Cancel Reply

The Washington Metropolitan Area Chapter(WMAC) of the National Association of Health Services Executives (NAHSE) was chartered in 1978 to educate and develop minority healthcare leaders while, in conjunction with the American College of Healthcare Executives (ACHE), promoting C-Suite diversity for Healthcare Organizations throughout Northern Virginia, Southern Maryland, and the District of Columbia. The Washington Metropolitan Area Chapter (WMAC) was one of the first two chapters founded by the Association, since its inception.

MD Anderson VC arm joins $25M funding round for cancer drug company | Health IT

Tags:

Previous PostSSM Health installs AI-based weapons detection system | Health IT

Next PostEmployee inappropriately accessed Nevada hospital's EHR system | Health IT

Leave a Reply Cancel Reply

Join the NAHSE-WMAC Mailing List

Contact Us